Drug giant to acquire NimbleGen
Roche will keep firm in Madison, where UW scientists started it
By KATHLEEN GALLAGHER
[email protected]
Posted: June 19, 2007
NimbleGen Systems Inc. on Tuesday became the second Madison company in as many months to raise hundreds of millions of dollars for shareholders and, its chairman said, will pave the way for more high-paying, high-tech jobs in the area.
The maker of gene chips used in drug research agreed to be acquired for $272.5 million by the diagnostics arm of Roche Holding AG, the giant Swiss pharmaceutical company. Roche plans to keep NimbleGen's 140 employees in Madison; Reykjavik, Iceland; and Waldkraiburg, Germany, the companies said.